Table 1 Total post-vaccine response following 104 vaccines as determined by the Area Under the MCIR curve based on vaccine dose, vaccine type, sex and age

From: Development of a personalized digital biomarker of vaccine-associated reactogenicity using wearable sensors and digital twin technology

 

Demographic and vaccine categories

n (%) with a detectablea response

Median (IQR) area under the MCIR curve

p-valueb of comparison of area under the MCIR curve

Vaccine Dose

1st Dose (n = 15)

8 (53.3)

0.043 (0.04)

1st vs 2nd dose: p = 0.01

1st vs 3rd dose: p = 0.06

2nd vs 3rd dose: p = 0.41

2nd Dose (n = 44)

31 (70.5)

0.083 (0.18)

3rd Dose (n = 45)

27 (60.0)

0.063 (0.13)

Vaccine Typec

mRNA-1273 (n = 36)

26 (72.2)

0.116 (0.19)

p = 0.06

BNT162b2 (n = 41)

24 (58.5)

0.055 (0.096)

Sexc

Females (n = 41)

25 (61.0)

0.070 (0.15)

p = 0.60

Males (n = 48)

33 (68.8)

0.065 (0.14)

Age by Tertilec

Lowest Tertile Age (range 19–28) (n = 31)

21 (67.7)

0.070 (0.13)

Lowest vs Middle Tertile: p = 0.99

Middle vs Highest Tertile: p = 0.13

Lowest vs Highest Tertile: p = 0.08

Middle Tertile Age (range 28–45.8) (n = 26)

20 (76.9)

0.056 (0.12)

Highest Tertile Age (range 45.8–69) (n = 29)

16 (55.2)

0.077 (0.20)

  1. aDetectable was defined as the presence of at least 50% of 15-min steps within a 6-hour sliding window having a MCIRs > 0.10.
  2. bp-values obtained using Kolmogorov–Smirnov (KS) test.
  3. cIncludes only second doses or higher.